Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (Dec 2019)

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep‐phenotyping case report

  • Elijah Mak,
  • Anastasia Bickerton,
  • Concepcion Padilla,
  • Madeleine J. Walpert,
  • Tiina Annus,
  • Liam R. Wilson,
  • Young T. Hong,
  • Tim D. Fryer,
  • Jonathan P. Coles,
  • Franklin I. Aigbirhio,
  • Bradley T. Christian,
  • Benjamin L. Handen,
  • William E. Klunk,
  • David K. Menon,
  • Peter J. Nestor,
  • Shahid H. Zaman,
  • Anthony J. Holland

DOI
https://doi.org/10.1016/j.dadm.2019.04.006
Journal volume & issue
Vol. 11, no. 1
pp. 654 – 658

Abstract

Read online

Abstract Introduction Comorbid Alzheimer disease pathologies are frequently found in people with Down syndrome (DS). We report a deep phenotyping study undertaken over 7 years in a participant with DS who was nondemented at baseline but developed dementia after 5 years. Methods Throughout the course of the study, the participant was seen 4 times (2010, 2013, 2015, and 2017). Multimodal neuroimaging, including three serial scans of [11C]‐PiB‐PET, four structural magnetic resonance imagings, as well as a [18F]‐AV1451 scan, was interpreted alongside detailed neuropsychological assessments over the study period. Results Amyloid beta accumulation preceded the onset of dementia and cognitive decline, which in turn corresponded to the predominant deposition of tau in temporoparietal cortices. Discussion Until now, data on the longitudinal trajectories of amyloid accumulation, tau pathology, and brain atrophy over multiple time points remain scarce in DS. This case report highlights the potential for deep phenotyping imaging to elucidate the substrates of cognitive decline in DS, although further longitudinal studies are necessary to clarify the relative contributions of both amyloid and tau.